par Goldman, Michel
Référence Nature reviews. Drug discovery, 10, 5, page (321-322)
Publication Publié, 2011-05
Article révisé par les pairs
Résumé : The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public-private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.